“a decreasing trend”

A decreasing trend was observed in low-density lipoprotein cholesterol (LDL-C) level of CAC patients as compared with those without CAC ( p = 0.0572).

A comparison of the items in each treatment group showed no difference in steatosis but revealed significantly decreased inflammation in HF_FT high and a decreasing trend in HF_ISS ( p = 0.0576) ( Figure 3 B–F).

A decreasing trend in the pGsk3β ( p=0.058 ) compared to the group treated only with palmitate was also observed ( Figure 5A ).

Then these cytokines exhibited a decreasing trend as patients recovered {TNF-α: P = 0.058 versus Controls (Day 14–17); IL-1α: P = 0.094 versus Controls (Day 14–17); IFN-γ: P = 0.919 versus Controls (Day 14–17)}.

However, the proportion of PCN/OXA/ERY/CLI-resistant CA-MRSA strains showed a decreasing trend (decrease per period, 0.70%; P =0.058; Fig. 1A ).

The crypt depth in group C showed a decreasing trend compared with group A ( p = 0.058), and the ratio of villus height to crypt depth in group C was significantly greater than that in groups A, B and D ( p < 0.05) ( Figure 2 , Figure S2 ).

The coverage of 6mA peaks in the genome showed a decreasing trend with the development of embryonic skeletal muscle (Spearman's r = −0.69, P = 0.058) ( Figure 3 A, Table S25).

A decreasing trend in polar Cx43 was present between the groups (aAF = 75.4 ± 12.1%, pAF = 71.3 ± 10.9%, persAF = 60.7 ± 13.7%, P = 0.058; Figure 5B ).

In 2015–2016, the lead level showed a decreasing trend that nearly reached the statistical significance ( P = 0.058).

Moreover, when compared to the baseline values and different time points of CASI scores, subjects in the EAHE group showed an increasing trend with marginal significance (71.75 ± 17.12 to 75.35 ± 15.86; p = 0.058) whereas the subjects in the placebo group showed a decreasing trend from the baseline to 49 weeks (73.52 ± 14.51 to 69.67 ± 16.62; p = 0.064).

In PE species, an increase in 16:1-PE and a decrease in 20:4-PE were observed, while 18:0-PE showed a decreasing trend (P = 0.058) ( Fig. 2 B).

In the CRRT group, serum levels of sVCAM-1 and sICAM-1 displayed a decreasing trend in survivors compared with non-survivors at the time of sepsis diagnosis ( p = 0.058, p = 0.119, respectively) ( Figure 5 ).

The pNN50 (the percentage of adjacent R-R intervals that differ from each other by more than 50 ms) of the female patients with achalasia showed a decreasing trend compared to that of the female controls (p=0.058).

At the protein level, PCNA was significantly reduced ( p < 0.01), and Pax7 showed a decreasing trend ( p = 0.0582, Figure 1C ).

6l ; p = 0.4209) and a decreasing trend of pAkt relative to Akt (Fig. 6l ; p = 0.0584) 24 h post-infection infection.

TG levels showed a decreasing trend with increasing plasma beta-amyloid category level, although this pattern did not reach conventional levels of statistical significance ( p = 0.0587).

Table 2 demonstrates a decreasing trend ( P =.059) in the percent correctness for the ChatGPT-4 answers moving from “Remember” to the classes of higher-order thinking.

Results demonstrate that tangible resources show a marginally significant mean value of the slope factor (slope mean = -0.04, p = 0.059; T1–3 means = 3.47, 3.42, and 3.41, respectively), which suggests that the mean level of tangible resources show a decreasing trend over time.

Compared with the TNH group, the MoCA score of the THL group showed a decreasing trend ( p = 0.059), but the difference was not significant.

We observed a significant increase of VEGFA ( p = 0.016) and a decreasing trend for KDR ( p = 0.059) in shERCC1 cells compared to NTCs (Fig. 2a ).

In the IVD + TNFα group, NO release decreased from Day 4 to Day 14 ( p < 0.01) with a decreasing trend from Day 11 to Day 14 ( p = 0.059; Figure 6A ).

The two neutrality tests were significant in temporal groups collected in 1960–1979 (for Tajima’s D P = 0.0013 and for Fu’s F S P = 0.011), whereas for the group collected in 1980–1993, Fu’s test value F S was significant ( P = 0.006), but Tajima’s D showed a decreasing trend ( P = 0.059).

Regarding the genes related to cell proliferation in the fetal intestine, compared with the CON group, the mRNA expression of ccnd1 was significantly decreased (p < 0.05; Figure S4 A), whereas the mRNA expression of Pcna showed a decreasing trend (p = 0.059; Figure S4 B) in the PDE group.

The incidence of moderate dysplasia or worse in groups A-C showed a decreasing trend (P=0.059, one-way ANOVA) from the 4NQO-exposed group (64.0%) to the free-SAB-treated (45.5%) and nano-SAB-treated (36.3%) groups.

Post hoc testing revealed that TRACP-5b at post-intervention (363 ± 112 mU/dL) was lower than that at pre-intervention (430 ± 154 mU/dL) ( p = 0.018), and TRACP-5b at 8 weeks (370 ± 114 mU/dL) revealed a decreasing trend compared to that with the pre-intervention ( p = 0.059).